These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 6497413)

  • 1. Failure of curettage and electrodesiccation for removal of basal cell carcinoma.
    Suhge d'Aubermont PC; Bennett RG
    Arch Dermatol; 1984 Nov; 120(11):1456-60. PubMed ID: 6497413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Curettage-electrodesiccation treatment of basal cell carcinomas.
    Kopf AW; Bart RS; Schrager D; Lazar M; Popkin GL
    Arch Dermatol; 1977 Apr; 113(4):439-43. PubMed ID: 848972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of curettage and electrodesiccation in the removal of basal cell carcinoma.
    Edens BL; Bartlow GA; Haghighi P; Astarita RW; Davidson TM
    J Am Acad Dermatol; 1983 Sep; 9(3):383-8. PubMed ID: 6630599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multivariate risk score for recurrence of cutaneous basal cell carcinomas.
    Dubin N; Kopf AW
    Arch Dermatol; 1983 May; 119(5):373-7. PubMed ID: 6847215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histological and immunohistochemical evaluation of basal cell carcinoma following curettage and electrodessication.
    Filho LL; de Oliveira de Avelar Alchorne A; Pereira GC; Lopes LR; de Carvalho TC
    Int J Dermatol; 2008 Jun; 47(6):610-4. PubMed ID: 18477158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective trial of curettage and cryosurgery in the management of non-facial, superficial, and minimally invasive basal and squamous cell carcinoma.
    Peikert JM
    Int J Dermatol; 2011 Sep; 50(9):1135-8. PubMed ID: 22126880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of basal cell carcinoma of the skin with curettage. II. A follow-up study.
    Reymann F
    Arch Dermatol; 1973 Oct; 108(4):528-31. PubMed ID: 4745285
    [No Abstract]   [Full Text] [Related]  

  • 8. Incomplete primary excision of cutaneous basal and squamous cell carcinomas in the Bay of Plenty.
    Talbot S; Hitchcock B
    N Z Med J; 2004 Apr; 117(1192):U848. PubMed ID: 15107870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The occurrence of residual or recurrent squamous cell carcinomas in organ transplant recipients after curettage and electrodesiccation.
    de Graaf YG; Basdew VR; van Zwan-Kralt N; Willemze R; Bavinck JN
    Br J Dermatol; 2006 Mar; 154(3):493-7. PubMed ID: 16445781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrence rates of aggressive histologic types of basal cell carcinoma after treatment with electrodesiccation and curettage alone.
    Blixt E; Nelsen D; Stratman E
    Dermatol Surg; 2013 May; 39(5):719-25. PubMed ID: 23379543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multifocal recurrent basal cell carcinoma following primary tumor treatment by electrodesiccation and curettage.
    Wagner RF; Cottel WI
    J Am Acad Dermatol; 1987 Dec; 17(6):1047-9. PubMed ID: 3429717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accuracy of serial transverse cross-sections in detecting residual basal cell carcinoma at the surgical margins of an elliptical excision specimen.
    Kimyai-Asadi A; Goldberg LH; Jih MH
    J Am Acad Dermatol; 2005 Sep; 53(3):469-74. PubMed ID: 16112355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Excision versus curettage and electrodesiccation as dermatologic office procedures for the treatment of basal-cell carcinomas.
    Popkin GL; Bart RS
    J Dermatol Surg; 1975 Mar; 1(1):33-5. PubMed ID: 1223143
    [No Abstract]   [Full Text] [Related]  

  • 14. Recurrence rates of treated basal cell carcinomas. Part 2: Curettage-electrodesiccation.
    Silverman MK; Kopf AW; Grin CM; Bart RS; Levenstein MJ
    J Dermatol Surg Oncol; 1991 Sep; 17(9):720-6. PubMed ID: 1820764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrence rates of primary basal cell carcinoma in facial risk areas treated with curettage and electrodesiccation.
    Rodriguez-Vigil T; Vázquez-López F; Perez-Oliva N
    J Am Acad Dermatol; 2007 Jan; 56(1):91-5. PubMed ID: 17190625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized, controlled surgical trial of preoperative tumor curettage of basal cell carcinoma in Mohs micrographic surgery.
    Huang CC; Boyce S; Northington M; Desmond R; Soong SJ
    J Am Acad Dermatol; 2004 Oct; 51(4):585-91. PubMed ID: 15389195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective Clinical Trial Comparing Curettage and Cryosurgery to Curettage and Electrodesiccation in the Management of Minimally Invasive Basal and Squamous Cell Carcinomas [Formula: see text].
    Fournier S; Laroche A; Leblanc M; Bourgeault E; Ulrich Singbo MN; Turcotte S; Blouin MM; Alain J
    J Cutan Med Surg; 2020; 24(6):596-600. PubMed ID: 32721237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biopsy followed by immediate curettage and electrodesiccation of suspected basal cell carcinomas at the first visit.
    White GM; Zhou HC; Burchette RJ
    JAMA Dermatol; 2013 Aug; 149(8):980-1. PubMed ID: 23760141
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of basal cell carcinoma with curettage alone.
    Barlow JO; Zalla MJ; Kyle A; DiCaudo DJ; Lim KK; Yiannias JA
    J Am Acad Dermatol; 2006 Jun; 54(6):1039-45. PubMed ID: 16713459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Basal cell carcinoma with mixed histology: a possible pathogenesis for recurrent skin cancer.
    Cohen PR; Schulze KE; Nelson BR
    Dermatol Surg; 2006 Apr; 32(4):542-51. PubMed ID: 16681663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.